rs2238079

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000719.7(CACNA1C):​c.478-84784T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.318 in 152,192 control chromosomes in the GnomAD database, including 8,925 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 8925 hom., cov: 33)

Consequence

CACNA1C
NM_000719.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.20

Publications

3 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.422 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000719.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
NM_000719.7
MANE Select
c.478-84784T>C
intron
N/ANP_000710.5
CACNA1C
NM_001167623.2
MANE Plus Clinical
c.478-84784T>C
intron
N/ANP_001161095.1Q13936-37
CACNA1C
NM_199460.4
c.478-84784T>C
intron
N/ANP_955630.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
ENST00000399603.6
TSL:5 MANE Plus Clinical
c.478-84784T>C
intron
N/AENSP00000382512.1Q13936-37
CACNA1C
ENST00000399655.6
TSL:1 MANE Select
c.478-84784T>C
intron
N/AENSP00000382563.1Q13936-12
CACNA1C
ENST00000682544.1
c.568-84784T>C
intron
N/AENSP00000507184.1A0A804HIR0

Frequencies

GnomAD3 genomes
AF:
0.318
AC:
48402
AN:
152074
Hom.:
8928
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.133
Gnomad AMI
AF:
0.434
Gnomad AMR
AF:
0.320
Gnomad ASJ
AF:
0.343
Gnomad EAS
AF:
0.256
Gnomad SAS
AF:
0.251
Gnomad FIN
AF:
0.395
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.426
Gnomad OTH
AF:
0.321
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.318
AC:
48412
AN:
152192
Hom.:
8925
Cov.:
33
AF XY:
0.313
AC XY:
23299
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.133
AC:
5509
AN:
41554
American (AMR)
AF:
0.320
AC:
4893
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.343
AC:
1190
AN:
3472
East Asian (EAS)
AF:
0.255
AC:
1322
AN:
5182
South Asian (SAS)
AF:
0.251
AC:
1207
AN:
4816
European-Finnish (FIN)
AF:
0.395
AC:
4177
AN:
10576
Middle Eastern (MID)
AF:
0.333
AC:
98
AN:
294
European-Non Finnish (NFE)
AF:
0.426
AC:
28945
AN:
67992
Other (OTH)
AF:
0.321
AC:
676
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1640
3281
4921
6562
8202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
488
976
1464
1952
2440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.391
Hom.:
6347
Bravo
AF:
0.306
Asia WGS
AF:
0.242
AC:
846
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
2.1
DANN
Benign
0.38
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2238079; hg19: chr12-2473358; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.